Inspira Technologies Oxy B.H.N. Ltd. Files Form 6-K on Respiratory Virus Response
Here are the key pieces of information extracted from the financial report:
- Report Details:
- Type: Form 6-K
- Filing Date: January 10, 2025
- Commission File Number: 001-40303
- Registrant Information:
- Company Name: Inspira Technologies Oxy B.H.N. Ltd.
- Address: 2 Ha-Tidhar St., Ra’anana 4366504, Israel
- Purpose of Filing:
- This report is a submission from a foreign private issuer under Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934.
- Press Release:
- The registrant issued a press release titled “Inspira™ Preparing Production in Response to Spread of Respiratory Virus in China,” which is included as Exhibit 99.1 in this report.
- Incorporation by Reference:
- Specific sections of the press release, including the first three paragraphs, fifth paragraph, and a section titled “Forward-Looking Statements,” are incorporated by reference into the registrant’s prior Registration Statements (Forms F-3 and S-8).
- Exhibit Information:
- Exhibit No.: 99.1
- Description: Press Release related to production preparation in response to a respiratory virus outbreak in China.
- Signature:
- The report is signed by Dagi Ben-Noon, Chief Executive Officer of Inspira Technologies Oxy B.H.N. Ltd., confirming the authenticity of the submission.
Insights:
- The company is responding proactively to a public health concern, indicating potential market dynamics that may affect demand for its products.
- The reference to prior registration statements suggests ongoing compliance with SEC regulations and potential future capital-raising activities.
- The timing of the report and the nature of the press release highlight the company's focus on market responsiveness and adaptability, which could be critical for stakeholders assessing its operational strategies.